Financial Statements — MEDS
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Cash & Equivalents | 2.46 | 0.05 | 4.23 | 0.42 | 2.52 |
| Accounts Receivable | 1.17 | 0.99 | -- | -- | -- |
| Inventory | 1.51 | 1.71 | 7.49 | 9.03 | 9.73 |
| Total Current Assets | 5.63 | 2.76 | 12.82 | 13.51 | 16.55 |
| Property, Plant & Equipment | 0.17 | 0.20 | 0.27 | 0.31 | 0.35 |
| Goodwill | 14.19 | 14.19 | 16.22 | 16.22 | 16.22 |
| Intangible Assets | 9.66 | 9.99 | 18.46 | 19.22 | 19.98 |
| Total Non-current Assets* | 27.13 | 27.37 | 39.96 | 40.72 | 41.51 |
| Total Assets | 32.76 | 30.13 | 52.78 | 54.23 | 58.06 |
| Short-term Debt | 19.21 | 15.17 | 12.21 | 13.18 | 17.71 |
| Total Current Liabilities | 39.41 | 32.20 | 32.74 | 42.40 | 46.23 |
| Long-term Debt | 31.81 | 27.77 | 24.81 | 23.28 | 24.12 |
| Total Non-current Liabilities* | 12.85 | 12.99 | 13.26 | 10.92 | 7.36 |
| Total Liabilities | 52.26 | 45.19 | 46.00 | 53.32 | 53.58 |
| Retained Earnings | (137.14) | (118.77) | (83.18) | (48.86) | (42.19) |
| Total Stockholder Equity | (19.50) | (15.06) | 6.78 | 0.91 | 4.48 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 |
|---|
| Total Revenue | 1.78 | 1.56 | 1.67 | 3.01 | 7.79 | 10.86 | -- |
| Cost of Revenue | 1.60 | 1.39 | 9.53 | 2.78 | 7.29 | 10.17 | -- |
| Gross Profit | 0.18 | 0.17 | (7.86) | 0.23 | 0.51 | 0.69 | -- |
| Selling, General & Admin | 7.06 | 4.87 | 4.13 | 30.17 | 4.86 | 31.17 | 4.35 |
| Total Operating Expenses | 7.53 | 6.19 | 17.50 | 31.78 | 6.01 | 32.04 | 5.00 |
| Operating Income | (7.35) | (6.02) | (25.35) | (31.55) | (5.50) | (31.35) | (3.75) |
| Pretax Income | (18.36) | (7.74) | (27.85) | (34.32) | (6.67) | (32.43) | (4.33) |
| Net Income | (18.36) | (7.74) | (27.85) | (34.32) | (6.67) | (32.43) | (4.33) |
| Basic EPS | (7.13) | (0.07) | (0.24) | (0.46) | (0.11) | (0.62) | (5.00) |
| Diluted EPS | (7.13) | (0.07) | (0.24) | (0.46) | (0.11) | (0.62) | (5.00) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Operating Cash Flow | (2.89) | (3.41) | (6.29) | (1.14) | (2.08) | (1.35) |
| Investing Cash Flow | (0.24) | (0.21) | (0.26) | (0.22) | (0.13) | (0.27) |
| Financing Cash Flow | 5.54 | 3.63 | 2.36 | 5.17 | 0.11 | 3.11 |
